Cancer drug Onivyde receives FDA approval
The Food and Drug Administration (FDA) has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, for patients with advanced pancreatic cancer who have been treated previously with gemcitabine-based chemotherapy. Read More »